TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10588226

Group type: EXPERIMENTAL
Intervention: ACEI nonadherence for one week
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: ACEI adherence for one week
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Partial adherence for one week
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Plasma AcSDKP
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Urine AcSDKP
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Serum ACE
Number of subjects: 39
Study: 8570252

Group type: EXPERIMENTAL
Intervention: Canalith repositioning procedure
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vestibular habituation exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study: 1929099

Group type: EXPERIMENTAL
Intervention: Estriol vaginal cream
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Trazodone and Estriol vaginal cream
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Veralipride
Number of subjects: 80
Study: 7124323

Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 2
Study: 27339446

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 25737517

Group type: EXPERIMENTAL
Intervention: Alendronate and calcium (bisphosphonate group, n = 14)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Calcium only (control group, n = 12)
Number of subjects: 26
Study: 24372760

Group type: EXPERIMENTAL
Intervention: Treadmill stress echocardiography (SE)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 400
Study: 22569132

Group type: EXPERIMENTAL
Intervention: Intraoperative FIO2 more than 0.9
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intraoperative FIO2 0.3
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (3-5 cm H2O)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No positive end-expiratory pressure
Number of subjects: 100
Study: 19713253

Group type: EXPERIMENTAL
Intervention: Repetitive paravertebral injections with a mixture of 10 mL 0.25% bupivacaine and 40 mg methylprednisolone acetate every 48 h for a week
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard therapy (oral antivirals and analgesics)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Repetitive paravertebral injections with local anesthetics and steroids
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both groups (paravertebral and standard therapy)
Number of subjects: 132
Study: 17124578

Group type: EXPERIMENTAL
Intervention: Terbinafine 150 mg daily for 6 days
Number of subjects: 12
Study: 15225946

Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g with codeine 60 mg
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo (Vitamin C 50 mg)
Number of subjects: 119
Study: 11172189

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard treatment with supplemental oxygen and no ventilatory support
Number of subjects: 52
Study: 9703405

Group type: EXPERIMENTAL
Intervention: First metacarpal osteotomy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Abductor pollicis longus tendon arthroplasty
Number of subjects: 17
Study: 8014493

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Trimetrexate plus leucovorin
Number of subjects: 215
Study: 2605073

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enflurane and Isoflurane
Number of subjects: 0
Study: 31558252

Group type: EXPERIMENTAL
Intervention: Clinician-centered teaching intervention and automatic reminders
Number of subjects: 525

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Overall participants
Number of subjects: 525
Study: 29060358

Group type: EXPERIMENTAL
Intervention: Activity monitoring using accelerometers over one week, fractal dimension D0 of activity series
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Activity monitoring using accelerometers over one week, Hurst exponents
Number of subjects: 813

Group type: COMPARATOR
Intervention: Activity monitoring using accelerometers over one week, approximate entropy
Number of subjects: 813
Study: 26231554

Group type: EXPERIMENTAL
Intervention: Biofeedback pelvic floor muscle exercise plus support group
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Biofeedback pelvic floor muscle exercise plus telephone contact
Number of subjects: 244

Group type: COMPARATOR
Intervention: Usual care without intervention
Number of subjects: 244
Study: 23675759

Group type: EXPERIMENTAL
Intervention: Disability awareness training program
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 156
Study: 21233425

Group type: EXPERIMENTAL
Intervention: Intensive early education program
Number of subjects: 111

Group type: COMPARATOR
Intervention: Nutritional supplements and parental counseling
Number of subjects: 111
Study: 20420791

Group type: EXPERIMENTAL
Intervention: Toprel 100 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topamax 100 mg
Number of subjects: 20
Study: 17084803

Group type: EXPERIMENTAL
Intervention: Lutein (10 or 20 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lutein + Zeaxanthin (10 or 20 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zeaxanthin (10 or 20 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 16281998

Group type: EXPERIMENTAL
Intervention: Chronic Disease Self‐Management Programme (CDSMP)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 476
Study: 12141769

Group type: EXPERIMENTAL
Intervention: Antibiotic packing (cotton gauze strips with polymyxin‐B‐sulfate and oxytetracycline ointment)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Antibiotic-free packing (polyvinyl acetate sponge and cotton gauze strips with sea‐salt ointment)
Number of subjects: 110
Study: 10199248

Group type: EXPERIMENTAL
Intervention: Active epidural analgesic paste
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo paste
Number of subjects: 60
Study: 7755526

Group type: EXPERIMENTAL
Intervention: Suppression group (instructed 'not to think of a spider')
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (instructed 'think about anything')
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups (third period instructed 'think about anything')
Number of subjects: 48
Study: 2304838

Group type: COMPARATOR
Intervention: Project nurse intervention involving daily hospital visits, coordination of discharge planning, and home visits post-discharge.
Number of subjects: 0
Study: 6992902

Group type: EXPERIMENTAL
Intervention: Salbutamol (6 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clomipramine (150 mg/day)
Number of subjects: 20
Study: 31187424

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 µg/kg IV followed by 0.5 µg/kg/h infusion during surgery)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Saline (same doses as DEX)
Number of subjects: 89
Study: 28484280

Group type: EXPERIMENTAL
Intervention: Lifestyle Advice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 0
Study: 25792695

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 138

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 138
Study: 22829349

Group type: EXPERIMENTAL
Intervention: Spontaneous self-directed pushing
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Prenatal perineal massage
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Combination of spontaneous pushing plus perineal massage
Number of subjects: 249

Group type: COMPARATOR
Intervention: Coached or directed pushing (routine care)
Number of subjects: 249
Study: 21894697

Group type: EXPERIMENTAL
Intervention: Najia fa
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nazi fa
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Yangzi Shike Zhuxue fa
Number of subjects: 30

Group type: COMPARATOR
Intervention: Najia fa vs Nazi fa
Number of subjects: 30

Group type: COMPARATOR
Intervention: Najia fa vs Yangzi Shike Zhuxue fa
Number of subjects: 30

Group type: COMPARATOR
Intervention: Najia fa vs Nazi fa in Wushi
Number of subjects: 30

Group type: COMPARATOR
Intervention: Najia fa vs Yangzi Shike Zhuxue fa in Wushi
Number of subjects: 30
Study: 19948625

Group type: EXPERIMENTAL
Intervention: Aripiprazole (5, 10, or 15 mg/day)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 17925431

Group type: EXPERIMENTAL
Intervention: Management at reference centers (RCs) using full polysomnography
Number of subjects: 88

Group type: COMPARATOR
Intervention: Management at non-reference centers (NRCs) using respiratory polygraphy
Number of subjects: 88
Study: 15152826

Group type: EXPERIMENTAL
Intervention: Enamel matrix proteins (EMD)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Subpedicle connective tissue graft (CTG)
Number of subjects: 70
Study: 11772231

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy administered for six months after surgery for Dukes C colon cancer
Number of subjects: 400000

Group type: EXPERIMENTAL
Intervention: Conventional chemotherapy for advanced CRC
Number of subjects: 400000

Group type: EXPERIMENTAL
Intervention: Newer therapeutic concepts based on molecular understanding
Number of subjects: 400000
Study: 9059228

Group type: EXPERIMENTAL
Intervention: Potato fibre (PF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maize fibre (MF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both fibres (PF and MF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basal diet (control)
Number of subjects: 0
Study: 7951554

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Patients with acromegaly
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Patients with GH deficiency
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Plasma IGF-I levels
Number of subjects: 120
Study: 3148145

Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam on nights N3, N4, N5
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.25 mg triazolam on nights N3, N4, N5
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo every night (control group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo on nights N0, N3, N5 (for groups B and C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Withdrawal night (N6)
Number of subjects: 24
Study: 30051753

Group type: EXPERIMENTAL
Intervention: EPI-743
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25749614

Group type: EXPERIMENTAL
Intervention: Balloon catheter dilation technology combined with a fibrolaryngoscope
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional nasal endoscopic sinus surgery
Number of subjects: 30
Study: 25516423

Group type: EXPERIMENTAL
Intervention: Psychoeducation and standard case management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard case management alone
Number of subjects: 0
Study: 22668619

Group type: EXPERIMENTAL
Intervention: Bitestrip
Number of subjects: 49

Group type: COMPARATOR
Intervention: Polysomnography
Number of subjects: 49
Study: 21092614

Group type: EXPERIMENTAL
Intervention: Electrical acupuncture stimulation therapy combined with pelvic floor muscle therapy (PFMT)
Number of subjects: 109

Group type: COMPARATOR
Intervention: PFMT (control group)
Number of subjects: 109
Study: 18176736

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (80% of maximum) twice weekly for 10 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual daily activities (Control group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 24
Study: 15014903

Group type: EXPERIMENTAL
Intervention: 11C‐choline PET
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: FDG PET
Number of subjects: 126
Study: 12162755

Group type: EXPERIMENTAL
Intervention: Filgrastim (granulocyte colony‐stimulating factor, G‐CSF)
Number of subjects: 82
Study: 9651731

Group type: EXPERIMENTAL
Intervention: Heart rate (HR) < 60 beats.min-1
Number of subjects: 8915

Group type: EXPERIMENTAL
Intervention: Heart rate (HR) > 100 beats.min-1
Number of subjects: 8915
Study: 8694984

Group type: EXPERIMENTAL
Intervention: Sunstar Do New Type toothbrush
Number of subjects: 33

Group type: COMPARATOR
Intervention: Reach Compact Head toothbrush
Number of subjects: 33

Group type: COMPARATOR
Intervention: New Dental‐H toothbrush
Number of subjects: 33
Study: 2540141

Group type: EXPERIMENTAL
Intervention: Progestin (20 mg tid medroxyprogesterone acetate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Estrogen (1.25 mg bid conjugated equine estrogens)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combined progestin and estrogen
Number of subjects: 12

Group type: COMPARATOR
Intervention: Mild exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 628065

Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31277790

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl 4 g/day
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study: 30695422

Group type: EXPERIMENTAL
Intervention: Muxiang Shunqi Pill (MSP), 6 g each time, three times per day, taken 30 min after dinner for 4 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mosapride Tablet (MT), 5 mg each time, three times per day, taken 30 min before dinner for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (20 subjects with normal physical examinations)
Number of subjects: 40
Study: 26092202

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 60
Study: 23083839

Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg (additional dose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21806771

Group type: EXPERIMENTAL
Intervention: Home telemonitoring of blood pressure and bilingual nurse counseling
Number of subjects: 359
Study: 19495545

Group type: EXPERIMENTAL
Intervention: fesoterodine 4 mg
Number of subjects: 1548

Group type: EXPERIMENTAL
Intervention: fesoterodine 8 mg
Number of subjects: 1548

Group type: EXPERIMENTAL
Intervention: tolterodine ER 4 mg
Number of subjects: 1548

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1548
Study: 16678593

Group type: EXPERIMENTAL
Intervention: Milrinone (n = 25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (n = 24)
Number of subjects: 49
Study: 15261707

Group type: EXPERIMENTAL
Intervention: Fluoxetine or venlafaxine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 11292002

Group type: EXPERIMENTAL
Intervention: ondansetron (4 microg/kg b.i.d.) + naltrexone (25 mg b.i.d.)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 9022118

Group type: EXPERIMENTAL
Intervention: 2.0% dorzolamide (three times daily)
Number of subjects: 184

Group type: COMPARATOR
Intervention: 0.5% timolol (twice daily)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: 2.0% dorzolamide (twice daily) added to 0.5% timolol
Number of subjects: 184
Study: 7939393

Group type: EXPERIMENTAL
Intervention: Loxiglumide (1200 mg orally)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standard meal with 15% soybean oil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard meal without fat
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Loxiglumide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standard meal with fat
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard meal in DU patients
Number of subjects: 20
Study: 2887519

Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: prazosin
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: propranolol
Number of subjects: 7
Study: 30646253

Group type: EXPERIMENTAL
Intervention: ASSIP intervention (3 manual-based therapy sessions followed by regular personalized letters over 24 months)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (single suicide risk assessment)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ASSIP intervention
Number of subjects: 120
Study: 26480931

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (DXM) 40 mg/d for 4 days
Number of subjects: 192

Group type: COMPARATOR
Intervention: Prednisone (PDN) 1.0 mg/kg daily for 4 weeks
Number of subjects: 192
Study: 24670122

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 200 mg daily for 12 weeks
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 400 mg daily for 12 weeks
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 600 mg daily for 12 weeks
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) 800 mg daily for 12 weeks
Number of subjects: 46
Study: 24147154

Group type: EXPERIMENTAL
Intervention: Educational posters displayed for 2 weeks in intervention schools
Number of subjects: 515

Group type: COMPARATOR
Intervention: No posters displayed in control schools
Number of subjects: 515
Study: 22586319

Group type: EXPERIMENTAL
Intervention: erlotinib
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: vandetanib
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: erlotinib plus bexarotene
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 255

Group type: COMPARATOR
Intervention: control group
Number of subjects: 255
Study: 18622420

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy and peripheral stem-cell reinfusion
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Duration of neutropenia >10 days
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Using the catheter for both stem-cell apheresis and high-dose chemotherapy
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Use of total parenteral nutrition (TPN)
Number of subjects: 392
Study: 17076227

Group type: EXPERIMENTAL
Intervention: B+Q (Bisoprolol + Quinapril)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: B+V (Bisoprolol + Valsartan)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: B+Q+V (Bisoprolol + Quinapril + Valsartan)
Number of subjects: 63
Study: 14533122

Group type: EXPERIMENTAL
Intervention: ECT (Electroconvulsive Therapy)
Number of subjects: 121
Study: 11031332

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS; 400 microg, twice daily)
Number of subjects: 407

Group type: COMPARATOR
Intervention: Placebo spray (twice daily)
Number of subjects: 407
Study: 9238581

Group type: EXPERIMENTAL
Intervention: Observational data from routine hospital statistics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustments to minimize bias and confounding
Number of subjects: 0
Study: 1468091

Group type: EXPERIMENTAL
Intervention: Cefadroxil monohydrate (30 mg/kg QD or 15 mg/kg BID)
Number of subjects: 1646
Study: 3740024

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol electrolyte gut lavage solution (old, n=105)
Number of subjects: 557

Group type: COMPARATOR
Intervention: Standard prep (old, n=71)
Number of subjects: 557
Study: 29393079

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (sterile 90% ethanol)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (sterile normal saline)
Number of subjects: 60
Study: 27447737

Group type: COMPARATOR
Intervention: Standard of care group
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard of care + adherence electronic monitoring group
Number of subjects: 123

Group type: COMPARATOR
Intervention: Integrated care group
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Adherence
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Baseline VASP-PRI
Number of subjects: 123
Study: 24796048

Group type: EXPERIMENTAL
Intervention: Combined therapy group (acupuncture, moxibustion, and modified Mojie tablet)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Acupuncture‐moxibustion group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medication group (gestrinone 2.5 mg, once a day, twice a week)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combined therapy group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medication group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Other groups (acupuncture‐moxibustion and combined therapy)
Number of subjects: 120
Study: 21934156

Group type: EXPERIMENTAL
Intervention: Yamax SW-200 pedometer worn over 365 consecutive days
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Data collection targeting certain months (e.g., May)
Number of subjects: 23
Study: 20543522

Group type: EXPERIMENTAL
Intervention: Diet plus pravastatin
Number of subjects: 0
Study: 18215613

Group type: EXPERIMENTAL
Intervention: Lisinopril (ACE inhibitor)
Number of subjects: 0
Study: 18647523

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 8 grams daily
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Glutathione (GSH) 1.2 grams daily
Number of subjects: 75
Study: 15511725

Group type: EXPERIMENTAL
Intervention: Tailored messages
Number of subjects: 1776

Group type: COMPARATOR
Intervention: Control messages
Number of subjects: 1776
Study: 11164155

Group type: EXPERIMENTAL
Intervention: 3 months of neoadjuvant hormonal treatment (NHT)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: 6 months of neoadjuvant hormonal treatment (NHT)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Immediate surgery
Number of subjects: 431